These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 372791)

  • 1. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
    Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
    Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis at the ouabain-resistance locus of 3.7.2C L5178Y cells by chromosomal mutagens.
    Amacher DE; Dunn EM
    Environ Mutagen; 1985; 7(4):523-33. PubMed ID: 2996875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci.
    Moore MM; Harrington-Brock K; Doerr CL; Dearfield KL
    Mutagenesis; 1989 Sep; 4(5):394-403. PubMed ID: 2687635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of 2-amino-N6-hydroxyadenine (AHA) at three loci in L5178Y/tk+/- mouse lymphoma cells: molecular and preliminary cytogenetic characterizations of AHA-induced tk-/- mutants.
    Clive D; Glover P; Krehl R; Poorman-Allen P
    Mutat Res; 1991 Aug; 253(1):73-82. PubMed ID: 1651447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
    Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Collard DD; Chen T
    Mutat Res; 2003 May; 537(1):21-8. PubMed ID: 12742504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
    Amacher DE; Paillet S; Ray VA
    Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Chen T; Harrington-Brock K; Moore MM
    Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
    Clive D; Glover P; Applegate M; Hozier J
    Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells by the clastogen ellipticine.
    Moore MM; Brock KH; Doerr CL; DeMarini DM
    Environ Mutagen; 1987; 9(2):161-70. PubMed ID: 3816714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.